Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced that results from the clinical case series analyzing the UltraPulse® CO2 laser system will

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In